We recently published a list of Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential. In this article, ...

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...

The market was pleased with the recent earnings report from Neurocrine Biosciences, Inc. ( NASDAQ:NBIX ), despite ...

Q1 2025 Earnings Call Transcript May 5, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS is $0 ...

We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to take a look at ...

Neurocrine Biosciences (NASDAQ:NBIX), a prominent healthcare company specializing in therapies for neurological and endocrine ...

Neurocrine Biosciences, the American biotech, has unveiled new data showing its drug Crenessity (crinecerfont) may help ...

Roberts, M.D., Chief Medical Officer, Neurocrine Biosciences. "CRENESSITY, a novel oral corticotropin-releasing factor type 1 receptor antagonist, has demonstrated the potential to achieve two key ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the launch of ConnectING with Carnie™, a multimedia awareness ...

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company ...